| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.083 | 0.1 |